GP6 and myocardial infarction: In conclusion, by combining several approaches and studying intracoronary and systemic platelets, the present study demonstrates altered GPVI signaling activation levels in response to receptor stimulation in platelets from STEMI patients, confirming GPVI – and its signaling pathway - as promising anti-thrombotic targets for myocardial infarction.